More articles from Article

You have access
Implementing a shared-care approach to improve the management of patients with pulmonary arterial hypertension
Majid M. Mughal, MD, Brian Mandell, MD, PhD, Karen James, MD, Kay Stelmach, RN and Omar A. Minai, MD

Cleveland Clinic Journal of Medicine April 2003, 70 (4 suppl 1) S28-S33;
You have access
Diagnosis and evaluation of pulmonary hypertension
Marie M. Budev, DO, MPH, Alejandro C. Arroliga, MD and Constance A. Jennings, MD

Cleveland Clinic Journal of Medicine April 2003, 70 (4 suppl 1) S9-S17;
You have access
Renal effects of nonselective NSAIDs and coxibs
Matthew R. Weir, MD

Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-53-SI-58;
You have access
Cyclooxygenase-2–selective inhibitors in the management of acute and perioperative pain
Warren A. Katz, MD

Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-65-SI-75;
You have access
COX-2–selective inhibitors in the treatment of arthritis
Thomas J. Schnitzer, MD, PhD and Marc C. Hochberg, MD, MPH

Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-20-SI-30;
You have access
Developing an economic rationale for the use of selective COX-2 inhibitors for patients at risk for NSAID gastropathy
A. Mark Fendrick, MD

Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-59-SI-64;
You have access
Outcomes studies of the gastrointestinal safety of cyclooxygenase-2 inhibitors
James M. Scheiman, MD

Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-40-SI-46;
You have access
Gastrointestinal safety and tolerability of non-selective non-steroidal anti-inflammatory agents and cyclooxygenase-2–selective inhibitors
David A. Peura, MD

Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-31-SI-39;
You have access
Cyclooxygenase-2–selective inhibitors: Translating pharmacology into clinical utility
Bruce N. Cronstein, MD

Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-13-SI-19;
You have access
Emerging options with coxib therapy
Mark J. Lema, MD, PhD

Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-76-SI-84;

Main menu

User menu

Search

More articles from Article

Pages

Navigate

Authors & Reviewers